The present results demonstrate a significant increase in CP-μOCT delineated crystals in gout vs. non-gout patients, suggesting that this technology can be used to improve our understanding of crystal-driven coronary pathogenesis and potentially monitor response to crystal abrogating therapy. Here, CP is linked to gout.